Webinar on personalized medicine

In this webinar, Doctor Marthe Kirkesæther Brun talks about research findings that can provide many patients with better treatment. The webinar is titled Personalized treatment of inflammatory diseases – monitoring of drug levels and antibodies. 

Premiere August 31 at 0830

The link can be found here, https://youtu.be/2RGv-5Om2-0

In our YouTube channel you can watch several webinars on current topics: //www https://www.youtube.com/@NKRR

We quote from VG's article about Marthe K. Brun's doctoral degree, May 16 of this year:

Many people with chronic inflammatory diseases have experienced their bodies forming antibodies against the medications they need to keep the disease at bay. This has resulted in poorer efficacy, or in the worst case, the medication has stopped working. This in turn can lead to disease flare-ups that set patients back in terms of health.

But now this patient group can look forward to a brighter future. The background is the so-called NOR-DRUM study, and not least the results of Marthe Kirkesæther Brun's doctoral work, which is linked to this study.

In 2019, Kirkesæther Brun started as a doctoral fellow at the REMEDY research center at Diakonhjemmet Hospital in Oslo. The research center specializes in rheumatology and musculoskeletal diseases, and has been very central to the aforementioned study.

On April 25th of this year, she defended her doctoral thesis, which was titled "Infliximab therapy in immune-mediated inflammatory diseases: Immunogenicity and proactive therapeutic drug monitoring.".

Simply explained, it is about the medication infliximab and other types of biological treatment that over 50,000 people with chronic inflammatory diseases in this country receive.

Two out of three people with inflammatory joint diseases who are treated with these medications achieve symptom freedom. Research into how to use the medication optimally, as well as mapping of risk factors that cause the medications not to work as expected, means that the last third now also have increased hope for help.